Inari Medical enters China distribution partnership [Yahoo! Finance]
Inari Medical, Inc. (NARI)
Company Research
Source: Yahoo! Finance
China-based medical device platform VFLO Medical for the distribution of its venous disease technology across the Greater China region. Under the new agreement, Inari notes it plans to leverage VFLO's infrastructure to commercialise its device, thereby, “benefitting from its local relationships and commercial expertise within the Greater China region”. A company that was incubated by 6 Dimensions and 120 Capital, VFLO will gain the right to use Inari's technology to manufacture products for domestic sale in Greater China. Inari CEO Drew Hykes said: “This joint venture allows many different types of patients and hospitals to access and benefit from Inari's technologies across multiple segments of China's complex healthcare delivery system.” Inari is chiefly known for making peripheral vascular devices, including catheters and thrombectomy systems. The company is perhaps best known for FlowTriever, the first mechanical thrombectomy system to receive clearance from the US Food and
Show less
Read more
Impact Snapshot
Event Time:
NARI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NARI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NARI alerts
High impacting Inari Medical, Inc. news events
Weekly update
A roundup of the hottest topics
NARI
News
- Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Truist Financial Co. from $50.00 to $63.00. They now have a "hold" rating on the stock.MarketBeat
- Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Inari Medical, Inc. (NARI) and Encourages Stockholders to Learn More About the InvestigationAccesswire
- Inari Medical, Inc. (NASDAQ: NARI) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $75.00 price target on the stock.MarketBeat
- Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Investors to Inquire about Securities InvestigationAccesswire
- NARI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into Inari Medical, Inc. and Encourages Investors to Contact the FirmAccesswire
NARI
Earnings
- 10/28/24 - Miss
NARI
Sec Filings
- 12/20/24 - Form 4
- 12/18/24 - Form 4
- 12/12/24 - Form 144
- NARI's page on the SEC website